Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image
Article image
Article image

DOG-DOSING SCHEME

New Drug To Be Considered , *- 1 ♦ F 4

House-to-house treatment of dogs and the use of a new drug, arecoline acetarsol, would be discussed by the hydatids control sub-committee of the Christchurch City Council when it met to consider all aspects of the antihydatids dog dosing scheme, said Cr. H. P. Smith, chairman of the sub-committee, yesterday. The sub-committee will meet within the next few days. It was appointed after the council’s scheme had been suspended after the deaths of three dogs on the openings day of the dosing scheme; but it has not met since. Cr. Smith said that the house-to-house scheme was being used in Riccarton borough and other local bodies’ areas, but in every case the area was more compact and different from the widespread city area of Christchurch. The new drug is reported to be slightly less efficient than arecoline hydrobromide and more expensive.

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/CHP19600324.2.40

Bibliographic details

Press, Volume XCIX, Issue 29162, 24 March 1960, Page 6

Word Count
150

DOG-DOSING SCHEME Press, Volume XCIX, Issue 29162, 24 March 1960, Page 6

DOG-DOSING SCHEME Press, Volume XCIX, Issue 29162, 24 March 1960, Page 6

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert